Novel Biomarkers and Theranostic Solutions

TRIMT is an inventor-founded, science- and data-driven company, led and operated by experts with strong scientific backgrounds, supported by an interdisciplinary advisory board.

For pharmaceutical and clinical developments addressing urgent unmet clinical needs, TRIMT relies on a consolidated network of academic and clinical collaborations and a selection of world-class industry partners.

TRIMT focuses its activities primarily on a class of cellular biomarkers called integrins to develop innovative clinical approaches to prolong life and improve quality of life for patients with the worst forms of cancer. In addition, TRIMT explores the fascinating areas of immune checkpoint inhibitors, small molecule drug conjugates (SMDCs) and intraoperative approaches using different modalities (optical, radioactive). The expertise is focused on discovery, preclinical development and clinical translation.